Silver Spring, Maryland–(ENEWSPF)–August 27, 2012. Samantha Lynn Inc. is voluntarily recalling 500 lots of Reumofan Plus Tablets to the consumer level due to findings of undeclared drug ingredients.
The Food and Drug Administration (FDA) sample analysis has found the product to contain methocarbamol and diclofenac. Use of this product could result in life-threatening hypersensitivity reactions and anaphylaxis and could cause a temporary and reversible increase in CNS depression. Samantha Lynn Inc. has not received any…
